BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17786132)

  • 1. HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.
    Garrido M; Mozos A; Martínez A; García F; Serafín A; Morente V; Caballero M; Gil C; Fumero E; Miró JM; Climent N; Gatell JM; Alos L
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):268-74. PubMed ID: 17786132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence.
    Alòs L; Navarrete P; Morente V; Garcia F; Garrido M; Plana M; Mozos A; López A; Gil C; Pumarola T; Caballero M; Blanch JL; Fumero E; Miró JM; Gallart T; Gatell JM; Campo E
    Mod Pathol; 2005 Jan; 18(1):127-36. PubMed ID: 15389256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy.
    Voltersvik P; Bostad L; Dyrhol-Riise AM; Eide GE; Røsok BI; Olofsson J; Asjö B
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):277-84. PubMed ID: 16540928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.
    Bucy RP; Hockett RD; Derdeyn CA; Saag MS; Squires K; Sillers M; Mitsuyasu RT; Kilby JM
    J Clin Invest; 1999 May; 103(10):1391-8. PubMed ID: 10330421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy.
    Macías J; Japón MA; Leal M; Sáez C; Pineda JA; Segura DI; Ortega J; Lissen E
    AIDS; 2001 Dec; 15(18):2371-8. PubMed ID: 11740187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients.
    Mozos A; Garrido M; Carreras J; Plana M; Diaz A; Alos L; Campo E; Garcia F; Martinez A
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):529-37. PubMed ID: 18193494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.
    Schacker TW; Nguyen PL; Martinez E; Reilly C; Gatell JM; Horban A; Bakowska E; Berzins B; van Leeuwen R; Wolinsky S; Haase AT; Murphy RL
    J Infect Dis; 2002 Oct; 186(8):1092-7. PubMed ID: 12355359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
    J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load.
    Nokta MA; Li XD; Al-Harthi L; Nichols J; Pou A; Asmuth D; Landay A; Pollard RB
    AIDS; 2002 Nov; 16(16):2119-27. PubMed ID: 12409732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy.
    Voltersvik P; Dyrhol-Riise AM; Bostad L; Røsok BI; Olofsson J; Asjö B
    APMIS; 2000; 108(7-8):539-50. PubMed ID: 11167551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection.
    Andersson J; Behbahani H; Lieberman J; Connick E; Landay A; Patterson B; Sönnerborg A; Loré K; Uccini S; Fehniger TE
    AIDS; 1999 Jul; 13(11):1295-303. PubMed ID: 10449281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.
    Orenstein JM; Bhat N; Yoder C; Fox C; Polis MA; Metcalf JA; Kovacs JA; Falloon J; Walker RE; Masur H; Lane HC; Davey RT
    AIDS; 2000 Aug; 14(12):1709-15. PubMed ID: 10985306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV DNA and immune alteration during successful HAART.
    Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
    Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.
    Gray CM; Lawrence J; Ranheim EA; Vierra M; Zupancic M; Winters M; Altman J; Montoya J; Zolopa A; Schapiro J; Haase AT; Merigan TC
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1357-69. PubMed ID: 11018855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
    García F; Alonso MM; Romeu J; Knobel H; Arrizabalaga J; Ferrer E; Dalmau D; Ruiz I; Vidal F; Frances A; Segura F; Gomez-Sirvent JL; Cruceta A; Clotet B; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):26-35. PubMed ID: 11064501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.
    Herbeuval JP; Nilsson J; Boasso A; Hardy AW; Vaccari M; Cecchinato V; Valeri V; Franchini G; Andersson J; Shearer GM
    AIDS; 2009 Jan; 23(1):35-40. PubMed ID: 19050384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ERK1/2 signaling pathway in Nef protein upregulation of the expression of the intercellular adhesion molecule 1 in endothelial cells.
    Fan Y; Liu C; Qin X; Wang Y; Han Y; Zhou Y
    Angiology; 2010 Oct; 61(7):669-78. PubMed ID: 20566577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.